Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer - Camblin, A. J., Pace, E. A., Adams, S., Curley, M. D., Rimkunas, V., Nie, L., Tan, G., Bloom, T., Iadevaia, S., Baum, J., Minx, C., Czibere, A., Louis, C. U., Drummond, D. C., Nielsen, U. B., Schoeberl, B., Pipas, J. M., Straubinger, R. M., Askoxylakis, V., Lugovskoy, A. A. (The American Association for Cancer Research (AACR), 2018)
6284479